Sponsored
Sponsored
Media Summary: One of the top topics at the World Economic Forum is generative The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data ... Keynote & Fireside Chat with Vas Narasimhan,

Novartis Ceo Discusses How Ai - Detailed Analysis & Overview

One of the top topics at the World Economic Forum is generative The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data ... Keynote & Fireside Chat with Vas Narasimhan, In this video, Shahram Ebadollahi, Head of Data Science and CNBC's Evolve Global Summit is a virtual conference of top business leaders with content from around the world. CNBC's ... Luca Finelli, Head of the Insights Strategy & Design team at

Vas Narasimhan never planned on becoming a Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian ... Digitization remains a priority within our business strategy. Leveraging the power of

Photo Gallery

Novartis CEO discusses how AI will impact drug development
Novartis CEO on the Future of Medicine | a16z Full Interview
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment
Novartis CEO Vas Narasimhan on The David Rubenstein Show
In A Decade From Now, A.I. Could Help Change Healthcare: Novartis CEO Vas Narasimhan | N18V
Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19
The Importance of AI in life sciences
Vas Narasimhan announcing the AI innovation lab.
Novartis CEO on the development of AI tech in health care
Democratizing access to AI
Novartis CEO Vas Narasimhan: ‘We really should be talking about out-of-pocket costs’ in the U.S.
View Detailed Profile
Novartis CEO discusses how AI will impact drug development

Novartis CEO discusses how AI will impact drug development

One of the top topics at the World Economic Forum is generative

Novartis CEO on the Future of Medicine | a16z Full Interview

Novartis CEO on the Future of Medicine | a16z Full Interview

a16z general partner Jorge Conde

Sponsored
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs

Novartis CEO on Acquisitions, AI, Weight-Loss Drugs

Novartis CEO

Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment

Episode 458: Novartis CEO Vas Narasimhan on Drug Development & AI's Role in Disease Treatment

The pharmaceutical industry is experiencing extraordinary innovation, fueled by breakthroughs in science, technology, and data ...

Novartis CEO Vas Narasimhan on The David Rubenstein Show

Novartis CEO Vas Narasimhan on The David Rubenstein Show

Novartis CEO

Sponsored
In A Decade From Now, A.I. Could Help Change Healthcare: Novartis CEO Vas Narasimhan | N18V

In A Decade From Now, A.I. Could Help Change Healthcare: Novartis CEO Vas Narasimhan | N18V

How can

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

Reimagining Medicine with Data & Digital | Novartis CEO at #VivaTech19

Keynote & Fireside Chat with Vas Narasimhan,

The Importance of AI in life sciences

The Importance of AI in life sciences

In this video, Shahram Ebadollahi, Head of Data Science and

Vas Narasimhan announcing the AI innovation lab.

Vas Narasimhan announcing the AI innovation lab.

Novartis

Novartis CEO on the development of AI tech in health care

Novartis CEO on the development of AI tech in health care

CNBC's Evolve Global Summit is a virtual conference of top business leaders with content from around the world. CNBC's ...

Democratizing access to AI

Democratizing access to AI

Luca Finelli, Head of the Insights Strategy & Design team at

Novartis CEO Vas Narasimhan: ‘We really should be talking about out-of-pocket costs’ in the U.S.

Novartis CEO Vas Narasimhan: ‘We really should be talking about out-of-pocket costs’ in the U.S.

Vas Narasimhan,

Own the Role You Have (Stop Thinking About the Next) | Novartis CEO Vas Narasimhan

Own the Role You Have (Stop Thinking About the Next) | Novartis CEO Vas Narasimhan

Vas Narasimhan never planned on becoming a

Novartis CEO discusses developing a new Covid-19 treatment

Novartis CEO discusses developing a new Covid-19 treatment

Vas Narasimhan,

Integrating AI for Revolutionary Drug Development and Discovery @ Novartis

Integrating AI for Revolutionary Drug Development and Discovery @ Novartis

Xiong Liu (Director of Data Science &

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Vas Narasimhan,

AI, vaccine distrust, & the future of healthcare: Novartis CEO

AI, vaccine distrust, & the future of healthcare: Novartis CEO

Can science prevail against this more turbulent backdrop of the Trump administration? Yahoo Finance executive editor Brian ...

AI for Life Residency Program

AI for Life Residency Program

Introducing the

Artificial Intelligence gives cancer research a boost.

Artificial Intelligence gives cancer research a boost.

Learn how

The role of digitization and AI in finding new medicines

The role of digitization and AI in finding new medicines

Digitization remains a priority within our business strategy. Leveraging the power of

Related Video Content

Novartis information

May 21, 2026 · For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one...

Novartis - Wikipedia information

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the...

Novartis AG | Swiss Pharmaceutical Giant | Britannica Money information

May 21, 2026 · Novartis AG, Swiss company that is one of the world’s largest manufacturers of pharmaceuticals. It was...

Novartis - LinkedIn information

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s...

Novartis AG (NVS) Stock Price, News, Quote & History - Yahoo Finance information

Novartis is a pharmaceutical company based in Switzerland. Its portfolio is focused primarily on the areas of...

Sponsored